Contact Us Product Guide Drug Information Site Map
$64.58 +$0.58 (Up 0.56%) Volume: 2,791,684 Nov 21, 2008 Barr Shareholders Approve Pending Teva Acquisition... Nov 19, 2008 Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and ... Nov 21, 2008 Barr Pharmaceuticals, Inc. Special Shareholders Meeting
Barr Pharmaceuticals, Inc.			Terms of Use Legal Notice Privacy Policy

Mission Corporate Profile Business Strategies Principal Facilities Government Affairs Corporate History

Generic Business Overview Barr Laboratories, Inc PLIVA d.d Generic Product Development Industry Links Clinical Trials

Proprietary Business Overview Proprietary Business Strategy Key Proprietary Products Proprietary Product Development Proprietary Sales Force Clinical Trials

Teva's Proposed Acquisition of Barr Corporate Profile Stock Quote Financials Fact Sheets Annual Reports 2008 Proxy Online Investor  Presentation Analyst Coverage Calendar Archives SEC Filings Corporate Governance Corporate Responsibility E-Mail Alerts Info Request

Career Opportunities Corporate Profile Mission Financials Generic Business Overview Key Generic Products Proprietary Business Overview Key Proprietary Products Proprietary Product Sales Forces